Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 2/20 | 0.45 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.45 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.45 |
| ▸ | KDM1A | O60341 | 4/20 | 0.38 |
| ▸ | NR1H2 | P55055 | 5/20 | 0.38 |
| ▸ | RXRA | P19793 | 4/20 | 0.38 |
| ▸ | NR1H3 | Q13133 | 4/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | DDB1 | Q16531 | 2/20 | 0.34 |
| ▸ | CRBN | Q96SW2 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | CALCA | P06881 | 1/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27245104 | 1.00 | OPRM1 (0.45) | OPRM1OPRK1OPRL1KDM1ANR1H2 | |
| SCHEMBL30599282 | 0.85 | NR1H2 (0.48) | KDM1ANR1H2RXRANR1H3 | |
| SCHEMBL24403238 | 0.85 | NR1H2 (0.48) | KDM1ANR1H2RXRANR1H3 | |
| SCHEMBL24403239 | 0.85 | NR1H2 (0.48) | KDM1ANR1H2RXRANR1H3 | |
| SCHEMBL30599281 | 0.85 | NR1H2 (0.48) | KDM1ANR1H2RXRANR1H3 | |
| SCHEMBL30890667 | 0.83 | OPRK1 (0.38) | OPRM1OPRK1OPRL1MAPK1MEN1 | |
| SCHEMBL24459256 | 0.81 | CALCA (0.45) | KDM1ANR1H2RXRANR1H3CALCA | |
| SCHEMBL30884885 | 0.81 | CALCA (0.45) | KDM1ANR1H2RXRANR1H3CALCA | |
| SCHEMBL30890377 | 0.80 | MAPK1 (0.35) | OPRM1OPRK1OPRL1KDM1ANR1H2 | |
| SCHEMBL30890470 | 0.80 | OPRM1 (0.38) | OPRM1OPRK1OPRL1KDM1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4612156-A1 | ANTI-VIRAL COMPOUNDS | Aligos Therapeutics, Inc. (US) | 2025-09-10 | — | — | EP | disclosed |
| WO-2024097296-A1 | ANTI-VIRAL COMPOUNDS | ALIGOS THERAPEUTICS, INC. (US) | 2024-05-10 | — | — | WO | disclosed |